AlphaFold predicted structure
COQ4 · Q9Y3A0

Mean pLDDT
88.1/ 100
Confident
265 residues
Confidence breakdown
- Very high(≥ 90)82%
- Confident(70–90)4%
- Low(50–70)2%
- Very low(< 50)12%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
coenzyme Q4
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Acute rhabdomyolysis
BIALLELIC, autosomal or pseudoautosomalAdult onset hereditary spastic paraplegia
BIALLELIC, autosomal or pseudoautosomalAtaxia and cerebellar anomalies - narrow panel
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalHereditary ataxia with onset in adulthood
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomal+7 more panels — install the extension to see the full list inline on any page.
neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome
spastic ataxia 10, autosomal recessive
neurodegenerative disease
spastic ataxia
hereditary disease
coenzyme Q10 deficiency
inborn mitochondrial metabolism disorder
mitochondrial disease
rhabdomyolysis
developmental disability
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial
Lyase that catalyzes the C1-decarboxylation of 4-hydroxy-3-methoxy-5-(all-trans-decaprenyl)benzoic acid into 2-methoxy-6-(all-trans-decaprenyl)phenol during ubiquinone biosynthesis
COQ4 · Q9Y3A0

Mean pLDDT
88.1/ 100
Confident
265 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0